Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CureVac (GB:0A9E)
LSE:0A9E
CureVac (0A9E) Ownership - Who Owns CureVac?
2 Followers
CureVac (0A9E) Ownership Overview
0.00% Insiders
1.18% Mutual Funds
1.22% Other Institutional Investors
97.60% Public Companies and
Individual Investors
The ownership structure of CureVac (GB:0A9E) stock is a mix of institutional, retail and individual investors. Approximately 2.40% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 97.60% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 19, 2024 | Alexander Zehnder Chief Executive Officer | Bought | $0 |
| Jan 06, 2024 | Alexander Zehnder Chief Executive Officer | Sold | $30561 |
| Jan 06, 2024 | Myriam Mendila Chief Development Officer | Sold | $21028 |
| Jan 05, 2024 | Malte Greune Chief Operating Officer | Sold | $28561 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $2096184 | |
| Dec 31, 2023 | Sold | $11553376 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,744,270 | Institution | 1.23% | 6,333,775 | |
| 2,221,847 | Institution | 0.99% | 5,128,023 | |
| 1,837,611 | Institution | 0.82% | 4,241,206 | |
| 497,906 | Institution | 0.22% | 1,149,167 | |
| 412,061 | Institution | 0.18% | 951,037 | |
| 157,451 | Institution | 0.07% | 363,397 | |
| 95,752 | Institution | 0.04% | 220,996 | |
| 73,188 | Institution | 0.03% | 168,918 | |
| 68,427 | Institution | 0.03% | 157,930 | |
| 63,237 | Institution | 0.03% | 145,951 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,837,611 | Institution | 0.82% | 4,241,206 | |
| 412,061 | Institution | 0.18% | 951,037 | |
| 157,451 | Institution | 0.07% | 363,397 | |
| 54,754 | Institution | 0.02% | 126,372 | |
| 45,335 | Institution | 0.02% | 104,633 | |
| 40,000 | Institution | 0.02% | 92,320 | |
| 37,664 | Institution | 0.02% | 86,929 | |
| 35,297 | Institution | 0.02% | 81,465 | |
| 19,663 | Institution | <0.01% | 45,382 | |
| 7,438 | Institution | <0.01% | 17,167 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns CureVac (GB:0A9E)?
According to the latest TipRanks data, approximately 1.22% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 97.60% is held by retail investors.
What percentage of CureVac (GB:0A9E) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.22% of CureVac (GB:0A9E) stock is held by institutional investors.
What percentage of CureVac (GB:0A9E) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.60% of CureVac (GB:0A9E) stock is held by retail investors.
Who owns the most shares of CureVac (GB:0A9E)?
Peter Kolchinsky owns the most shares of CureVac (GB:0A9E).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.